Anne Nielsen1,2, Mikkel Bo Hansen3, Anna Tietze3,4, Kim Mouridsen3. 1. From the Department of Clinical Medicine, Center of Functionally Integrative Neuroscience and MINDLAB, Aarhus University, Denmark (A.N., M.B.H., A.T., K.M.) anne@cfin.au.dk. 2. Cercare Medical ApS, Aarhus, Denmark (A.N.). 3. From the Department of Clinical Medicine, Center of Functionally Integrative Neuroscience and MINDLAB, Aarhus University, Denmark (A.N., M.B.H., A.T., K.M.). 4. Institute of Neuroradiology, Charité Universitätsmedizin, Germany (A.T.).
Abstract
BACKGROUND AND PURPOSE: Treatment options for patients with acute ischemic stroke depend on the volume of salvageable tissue. This volume assessment is currently based on fixed thresholds and single imagine modalities, limiting accuracy. We wish to develop and validate a predictive model capable of automatically identifying and combining acute imaging features to accurately predict final lesion volume. METHODS: Using acute magnetic resonance imaging, we developed and trained a deep convolutional neural network (CNNdeep) to predict final imaging outcome. A total of 222 patients were included, of which 187 were treated with rtPA (recombinant tissue-type plasminogen activator). The performance of CNNdeep was compared with a shallow CNN based on the perfusion-weighted imaging biomarker Tmax (CNNTmax), a shallow CNN based on a combination of 9 different biomarkers (CNNshallow), a generalized linear model, and thresholding of the diffusion-weighted imaging biomarker apparent diffusion coefficient (ADC) at 600×10-6 mm2/s (ADCthres). To assess whether CNNdeep is capable of differentiating outcomes of ±intravenous rtPA, patients not receiving intravenous rtPA were included to train CNNdeep,-rtpa to access a treatment effect. The networks' performances were evaluated using visual inspection, area under the receiver operating characteristic curve (AUC), and contrast. RESULTS: CNNdeep yields significantly better performance in predicting final outcome (AUC=0.88±0.12) than generalized linear model (AUC=0.78±0.12; P=0.005), CNNTmax (AUC=0.72±0.14; P<0.003), and ADCthres (AUC=0.66±0.13; P<0.0001) and a substantially better performance than CNNshallow (AUC=0.85±0.11; P=0.063). Measured by contrast, CNNdeep improves the predictions significantly, showing superiority to all other methods (P≤0.003). CNNdeep also seems to be able to differentiate outcomes based on treatment strategy with the volume of final infarct being significantly different (P=0.048). CONCLUSIONS: The considerable prediction improvement accuracy over current state of the art increases the potential for automated decision support in providing recommendations for personalized treatment plans.
BACKGROUND AND PURPOSE: Treatment options for patients with acute ischemic stroke depend on the volume of salvageable tissue. This volume assessment is currently based on fixed thresholds and single imagine modalities, limiting accuracy. We wish to develop and validate a predictive model capable of automatically identifying and combining acute imaging features to accurately predict final lesion volume. METHODS: Using acute magnetic resonance imaging, we developed and trained a deep convolutional neural network (CNNdeep) to predict final imaging outcome. A total of 222 patients were included, of which 187 were treated with rtPA (recombinant tissue-type plasminogen activator). The performance of CNNdeep was compared with a shallow CNN based on the perfusion-weighted imaging biomarker Tmax (CNNTmax), a shallow CNN based on a combination of 9 different biomarkers (CNNshallow), a generalized linear model, and thresholding of the diffusion-weighted imaging biomarker apparent diffusion coefficient (ADC) at 600×10-6 mm2/s (ADCthres). To assess whether CNNdeep is capable of differentiating outcomes of ±intravenous rtPA, patients not receiving intravenous rtPA were included to train CNNdeep,-rtpa to access a treatment effect. The networks' performances were evaluated using visual inspection, area under the receiver operating characteristic curve (AUC), and contrast. RESULTS: CNNdeep yields significantly better performance in predicting final outcome (AUC=0.88±0.12) than generalized linear model (AUC=0.78±0.12; P=0.005), CNNTmax (AUC=0.72±0.14; P<0.003), and ADCthres (AUC=0.66±0.13; P<0.0001) and a substantially better performance than CNNshallow (AUC=0.85±0.11; P=0.063). Measured by contrast, CNNdeep improves the predictions significantly, showing superiority to all other methods (P≤0.003). CNNdeep also seems to be able to differentiate outcomes based on treatment strategy with the volume of final infarct being significantly different (P=0.048). CONCLUSIONS: The considerable prediction improvement accuracy over current state of the art increases the potential for automated decision support in providing recommendations for personalized treatment plans.
Authors: Y W Lui; P D Chang; G Zaharchuk; D P Barboriak; A E Flanders; M Wintermark; C P Hess; C G Filippi Journal: AJNR Am J Neuroradiol Date: 2020-07-30 Impact factor: 3.825
Authors: Julian Klug; Elisabeth Dirren; Maria G Preti; Paolo Machi; Andreas Kleinschmidt; Maria I Vargas; Dimitri Van De Ville; Emmanuel Carrera Journal: J Cereb Blood Flow Metab Date: 2020-06-05 Impact factor: 6.200
Authors: Yoon-Chul Kim; Jong-Won Chung; Oh Young Bang; Mihee Hong; Woo-Keun Seo; Gyeong-Moon Kim; Eung Yeop Kim; Jin Soo Lee; Ji Man Hong; David S Liebeskind; Jeffrey L Saver Journal: Transl Stroke Res Date: 2022-05-21 Impact factor: 6.829
Authors: Anke Wouters; David Robben; Soren Christensen; Henk A Marquering; Yvo B W E M Roos; Robert J van Oostenbrugge; Wim H van Zwam; Diederik W J Dippel; Charles B L M Majoie; Wouter J Schonewille; Aad van der Lugt; Maarten Lansberg; Gregory W Albers; Paul Suetens; Robin Lemmens Journal: Stroke Date: 2021-09-30 Impact factor: 7.914
Authors: Raphael Meier; Paula Lux; B Med; Simon Jung; Urs Fischer; Jan Gralla; Mauricio Reyes; Roland Wiest; Richard McKinley; Johannes Kaesmacher Journal: Radiol Artif Intell Date: 2019-09-11
Authors: J E Soun; D S Chow; M Nagamine; R S Takhtawala; C G Filippi; W Yu; P D Chang Journal: AJNR Am J Neuroradiol Date: 2020-11-26 Impact factor: 3.825